They have shown that such a biosensor efficiently distinguishes mean values of urinary APOA2 protein concentrations between patients with bladder cancer (29–344 ng/mL−1) and those with hernia (0.425–9.47 ng/mL−1) [37]. This evidence concerns the gene APOA2 and urinary bladder carcinoma.